Actively Recruiting
Prophylactic Pregabalin Treatment Following Spinal Cord Injury
Led by Loewenstein Hospital · Updated on 2025-06-24
50
Participants Needed
1
Research Sites
238 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients arriving to rehabilitation up to 3 months following SCI will be given (study group) or not (control group) Lyrica (75X2). They will be followed for central pain development.
CONDITIONS
Official Title
Prophylactic Pregabalin Treatment Following Spinal Cord Injury
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Up to 3 months following traumatic or non-traumatic spinal cord lesion
- Ability to give informed consent and cooperate
You will not qualify if you...
- Pregnancy
- Neurological or other medical conditions that may interfere with sensation
- Neuropathic-like pain before recruitment (such as burning, numbness, tingling, or electric shock sensations)
- Currently treated with Pregabalin
- Blood creatinine levels greater than 1.2 or creatinine clearance less than 60
- Sensitivity to lactose
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Loewenstein Rehabilitation Hospital
Raanana, Israel
Actively Recruiting
Research Team
A
Amiram Catz, Prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here